Found: 73
Select item for more details and to access through your institution.
Consensus statement from the American Cancer Society Workshop on neuroblastoma screening: Do benifit from mass screening for neuroblastoma?
- Published in:
- CA: A Cancer Journal for Clinicians, 1991, v. 41, n. 4, p. 227, doi. 10.3322/canjclin.41.4.227
- By:
- Publication type:
- Article
Epigenetic alterations differ in phenotypically distinct human neuroblastoma cell lines.
- Published in:
- 2010
- By:
- Publication type:
- journal article
Epigenetic alterations differ in phenotypicallydistinct human neuroblastoma cell lines.
- Published in:
- BMC Cancer, 2010, v. 10, p. 286, doi. 10.1186/1471-2407-10-286
- By:
- Publication type:
- Article
Composite tumor with pheochromocytoma and immature neuroblastoma: report of two cases with cytogenetic analysis and discussion of current terminology.
- Published in:
- 2017
- By:
- Publication type:
- journal article
The Experience of Children With Neuroblastoma and Their Parents During Single-Room Isolation for 131 I-Metaiodobenzylguanidine Therapy: A Qualitative Descriptive Study.
- Published in:
- Journal of Pediatric Hematology/Oncology Nursing, 2022, v. 39, n. 5, p. 304, doi. 10.1177/27527530211068749
- By:
- Publication type:
- Article
MYCN-mediated regulation of the MRP1 promoter in human neuroblastoma.
- Published in:
- Oncogene, 2004, v. 23, n. 3, p. 753, doi. 10.1038/sj.onc.1207151
- By:
- Publication type:
- Article
Unrealistic parental expectations for cure in poor-prognosis childhood cancer.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Neuroblastoma of undifferentiated subtype, prognostic significance of prominent nucleolar formation, and MYC/MYCN protein expression: a report from the Children's Oncology Group.
- Published in:
- 2013
- By:
- Publication type:
- journal article
Neuroblastoma of Undifferentiated Subtype, Prognostic Significance of Prominent Nucleolar Formation, and MYC/MYCN Protein Expression.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 20, p. 3718, doi. 10.1002/cncr.28251
- By:
- Publication type:
- Article
Collection, storage, and infusion of stem cells in children with high-risk neuroblastoma: Saving for a rainy day.
- Published in:
- Pediatric Blood & Cancer, 2006, v. 46, n. 7, p. 719, doi. 10.1002/pbc.20769
- By:
- Publication type:
- Article
Positive association between congenital anomalies and risk of neuroblastoma.
- Published in:
- Pediatric Blood & Cancer, 2005, v. 45, n. 5, p. 649, doi. 10.1002/pbc.20263
- By:
- Publication type:
- Article
Trans-population Analysis of Genetic Mechanisms of Ethnic Disparities in Neuroblastoma Survival.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2013, v. 105, n. 4, p. 302, doi. 10.1093/jnci/djs503
- By:
- Publication type:
- Article
ABCC Multidrug Transporters in Childhood Neuroblastoma: Clinical and Biological Effects Independent of Cytotoxic Drug Efflux.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2011, v. 103, n. 16, p. 1236, doi. 10.1093/jnci/djr256
- By:
- Publication type:
- Article
Natural killer cell lymphoma.
- Published in:
- Cancer (0008543X), 2001, v. 91, n. 4, p. 642, doi. 10.1002/1097-0142(20010215)91:4<642::AID-CNCR1047>3.0.CO;2-2
- By:
- Publication type:
- Article
Protocol for the Examination of Specimens From Patients With Neuroblastoma and Related Neuroblastic Tumors.
- Published in:
- Archives of Pathology & Laboratory Medicine, 2005, v. 129, n. 7, p. 874, doi. 10.5858/2005-129-874-pfteos
- By:
- Publication type:
- Article
Factors influencing parents' choice of palliative treatment goals for children with relapsed or refractory neuroblastoma: A multi‐site longitudinal survey study.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 7, p. 1101, doi. 10.1002/cncr.35149
- By:
- Publication type:
- Article
Efficacy of post‐induction therapy for high‐risk neuroblastoma patients with end‐induction residual disease.
- Published in:
- Cancer (0008543X), 2022, v. 128, n. 15, p. 2967, doi. 10.1002/cncr.34263
- By:
- Publication type:
- Article
Age-Dependent Prognostic Effect by Mitosis-Karyorrhexis Index in Neuroblastoma: A Report from the Children's Oncology Group.
- Published in:
- Pediatric & Developmental Pathology, 2014, v. 17, n. 6, p. 441, doi. 10.2350/14-06-1505-OA.1
- By:
- Publication type:
- Article
Comparative pharmacokinetics, safety, and tolerability of two sources of ch14.18 in pediatric patients with high-risk neuroblastoma following myeloablative therapy.
- Published in:
- 2016
- By:
- Publication type:
- journal article
RNA Expression of the WT1 Gene in Wilms' Tumors in Relation to Histology.
- Published in:
- JNCI: Journal of the National Cancer Institute, 1992, v. 84, n. 3, p. 181
- By:
- Publication type:
- Article
Secreted Protein Acidic and Rich in Cysteine Is a Matrix Scavenger Chaperone.
- Published in:
- PLoS ONE, 2011, v. 6, n. 9, p. 1, doi. 10.1371/journal.pone.0023880
- By:
- Publication type:
- Article
Intraspinal Wilms' tumor metastases.
- Published in:
- 1994
- By:
- Publication type:
- journal article
Long‐term follow‐up of patients with intermediate‐risk neuroblastoma treated with response‐ and biology‐based therapy: A report from the Children's Oncology Group study ANBL0531.
- Published in:
- Pediatric Blood & Cancer, 2024, v. 71, n. 8, p. 1, doi. 10.1002/pbc.31089
- By:
- Publication type:
- Article
In Memoriam: Sharon B. Murphy, MD (1943–2023).
- Published in:
- 2024
- By:
- Publication type:
- Obituary
Adrenergic and mesenchymal signatures are identifiable in cell-free DNA and correlate with metastatic disease burden in children with neuroblastoma.
- Published in:
- Pediatric Blood & Cancer, 2024, v. 71, n. 1, p. 1, doi. 10.1002/pbc.30735
- By:
- Publication type:
- Article
Multimodality treatment for recurrent neuroblastoma in the central nervous system.
- Published in:
- Pediatric Blood & Cancer, 2023, v. 70, n. 4, p. 1, doi. 10.1002/pbc.30227
- By:
- Publication type:
- Article
Rethinking high‐risk neuroblastoma treatment.
- Published in:
- Pediatric Blood & Cancer, 2022, v. 69, n. 8, p. 1, doi. 10.1002/pbc.29730
- By:
- Publication type:
- Article
A nomogram of clinical and biologic factors to predict survival in children newly diagnosed with high‐risk neuroblastoma: An International Neuroblastoma Risk Group project.
- Published in:
- Pediatric Blood & Cancer, 2021, v. 68, n. 3, p. 1, doi. 10.1002/pbc.28794
- By:
- Publication type:
- Article
Association between end-induction response according to the revised International Neuroblastoma Response Criteria (INRC) and outcome in high-risk neuroblastoma patients.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The prognostic strength of serum LDH and serum ferritin in children with neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Paraneoplastic opsoclonus myoclonus syndrome associated with inflammatory myofibroblastic tumor in a pediatric patient.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Role of the extent of prophylactic regional lymph node radiotherapy on survival in high-risk neuroblastoma: A report from the COG A3973 study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
The challenge of defining "ultra-high-risk" neuroblastoma.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Computer-assisted Curie scoring for metaiodobenzylguanidine (MIBG) scans in patients with neuroblastoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Rebound thymic hyperplasia following high dose chemotherapy and stem cell transplant in three neuroblastoma patients.
- Published in:
- 2017
- By:
- Publication type:
- case study
A Phase I New Approaches to Neuroblastoma Therapy Study of Buthionine Sulfoximine and Melphalan With Autologous Stem Cells for Recurrent/Refractory High-Risk Neuroblastoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Segmental Chromosomal Aberrations in Localized Neuroblastoma Can be Detected in Formalin-Fixed Paraffin-Embedded Tissue Samples and Are Associated With Recurrence.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Stem Cell Transplant-Associated Wernicke Encephalopathy in a Patient with High-Risk Neuroblastoma.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Second malignancies in patients with neuroblastoma: The effects of risk-based therapy.
- Published in:
- Pediatric Blood & Cancer, 2015, v. 62, n. 1, p. 128, doi. 10.1002/pbc.25249
- By:
- Publication type:
- Article
Significance of clinical and biologic features in Stage 3 neuroblastoma: A report from the International Neuroblastoma Risk Group project.
- Published in:
- Pediatric Blood & Cancer, 2014, v. 61, n. 11, p. 1932, doi. 10.1002/pbc.25134
- By:
- Publication type:
- Article
Secondary malignant neoplasms after high-dose chemotherapy and autologous stem cell rescue for high-risk neuroblastoma.
- Published in:
- Pediatric Blood & Cancer, 2014, v. 61, n. 8, p. 1350, doi. 10.1002/pbc.25033
- By:
- Publication type:
- Article
Time to disease progression in children with relapsed or refractory neuroblastoma treated with ABT-751: A report from the Children's Oncology Group (ANBL0621).
- Published in:
- Pediatric Blood & Cancer, 2014, v. 61, n. 6, p. 990, doi. 10.1002/pbc.24900
- By:
- Publication type:
- Article
Treatment of two cases with refractory, metastatic intermediate-risk neuroblastoma with isotretenoin alone or observation.
- Published in:
- Pediatric Blood & Cancer, 2014, v. 61, n. 6, p. 1104, doi. 10.1002/pbc.24889
- By:
- Publication type:
- Article
Neuroblastoma in older children, adolescents and young adults: A report from the International Neuroblastoma Risk Group project.
- Published in:
- Pediatric Blood & Cancer, 2014, v. 61, n. 4, p. 627, doi. 10.1002/pbc.24777
- By:
- Publication type:
- Article
Children's Oncology Group's 2013 blueprint for research: Neuroblastoma.
- Published in:
- Pediatric Blood & Cancer, 2013, v. 60, n. 6, p. 985, doi. 10.1002/pbc.24433
- By:
- Publication type:
- Article
Progression-free survival of two cases of high-risk neuroblastoma with refractory/relapsed disease following surgery alone.
- Published in:
- Pediatric Blood & Cancer, 2013, v. 60, n. 3, p. 512, doi. 10.1002/pbc.24385
- By:
- Publication type:
- Article
Peripheral neuroblastic tumors with genotype-phenotype discordance: A report from the Children's Oncology Group and the International Neuroblastoma Pathology Committee.
- Published in:
- Pediatric Blood & Cancer, 2013, v. 60, n. 3, p. 363, doi. 10.1002/pbc.24238
- By:
- Publication type:
- Article
Two cases of localized neuroblastoma with multiple segmental chromosomal alterations and metastatic progression.
- Published in:
- Pediatric Blood & Cancer, 2013, v. 60, n. 2, p. 332, doi. 10.1002/pbc.24311
- By:
- Publication type:
- Article
Sorafenib inhibits neuroblastoma cell proliferation and signaling, blocks angiogenesis, and impairs tumor growth.
- Published in:
- Pediatric Blood & Cancer, 2012, v. 59, n. 4, p. 642, doi. 10.1002/pbc.24004
- By:
- Publication type:
- Article
Locoregional MYCN-amplified neuroblastoma.
- Published in:
- Pediatric Blood & Cancer, 2012, v. 59, n. 4, p. 736, doi. 10.1002/pbc.24003
- By:
- Publication type:
- Article